The Schilling test is commonly used to measure absorption of vitamin B12 in aqueous form. This correlates with the absorption of vitamin B12 from food in healthy subjects.' There are, however, patients with vitamin BI2 deficiency whose Schilling test is normal but who show reduced absorption of the vitamin when it is bound in vitro to protein prior to ingestion.24 This combination of normal aqueous but decreased protein bound absorption is associated with achlorhydria and may be seen after partial gastrectomy5 or vagotomyS 6 in atrophic gastritis3 '7 and during treatment with cimetidine.8 9 Patients with atrophic gastritis may have a subnormal serum vitamin B,2 concentration despite a normal Schilling test'0 which, on occasion, has been associated with megaloblastic anaemia4 6 
Results
The figure shows the results of the absorption tests in all subjects.
In the control group, the mean excretion of isotope in the protein bound part of the test was 2-7% (SEM 0-4%). In those aged under 60 it was 3-6 (0 5)% (range 1 3-7-5) and in older controls it was 1-4 (0-2)% (range 0 6-3 6). We interpreted an excretion of less than I -0% as abnormal in subjects under 60 years of age, and less than 0 5% as abnormal in older subjects.
In the patients with pernicious anaemia excretion of aqueous vitamin was abnormal in all cases. Protein bound vitamin B12 absorption was defective in 17, but normal in two elderly patients. All seven patients who had had partial gastrectomy showed subnormal excretion in one or both parts of the dual test. In four both parts were normal, in two the protein bound part was low, and in one only the aqueous absorption was low.
Of the other patients with low serum vitamin B12 and iron deficiency, five had a low protein bound absorption, three malabsorption of both forms, and two a low aqueous absorption. In three, both parts of the test were normal.
No consistent results were obtained in the heterogenous group with malabsorptive states, but three patients, one with bacterial contamination of the bowel, one with subtotal villous atrophy, and one receiving metformin, had normal protein bound B12 absorption with abnormal aqueous absorption.
All four patients with alcohol abuse showed a subnormal protein bound vitamin B12 absorption, and one patient also had a subnormal aqueous result. Two patients who abstained from alcohol for several months showed, on repeat testing, improved absorption of protein bound B12 from 0% (aqueous 36%) to 7 2% (aqueous 32-1%) and 0 1% (aqueous 11%) to 13% (aqueous 18-3%). Two patients with folate deficiency had subnormal protein bound B12 absorption and one patient had subnormal aqueous (7-5%) but normal protein bound absorption.
All patients in the idiopathic group had normal aqueous absorption and four had subnormal proteinbound B12 absorption. Three of these four had parietal cell antibodies which were not present in the others. One with parietal cell antibodies also had intrinsic factor antibodies, and a year later had an abnormal Schilling test (7-1%).
In II subjects a comparison was made between the aqueous part of the dual test and a standard Schilling test performed separately. The mean excretion in the aqueous part was 7-8% compared with 8 0% in the Schilling test (paired t = 0-172, NS). Table 2 shows that the reproducibility of the test was good.
Discussion
A combined test of aqueous and protein bound cyanocobalamin is more convenient for both patient and laboratory than two separate tests. Doscherholmen et al12 described a combined test using egg yolk as a binder, but the preparation of the test doses is intricate. Our objective was to develop a test requiring only minimal preparation of the reagents and suitable for use by an isotope laboratory with appropriate counting equipment.
We chose a two hour interval between doses'3 to lessen the risk of free 58Co vitamin B12 being taken up by unbound chicken serum. The order in which the aqueous and protein bound vitamin were given was important. Giving the aqueous dose first, seemed to reduce the absorption of the protein bound isotope. The reason for this is not clear because in other experiments, when two aqueous doses were given separately, little or no inhibition was noted. Results proved satisfactory when the protein bound dose was given first.
An important feature of this dual test is the comparability of the aqueous part with the standard Schilling test. The reproducibility of the aqueous part was as good as that of the Schilling test.14 15 The protein bound part of the test was also reproducible, repeat tests showing no change in clinical interpretation. The variability that was noted may reflect inadequate urine collection. As with any test entailing prolonged urine collection, the importance of collecting all urine has to be emphasised to the patient. We had to discard very few results because of obvious undercollection, but the omission of a small volume at the time of maximal isotope excretion would go undetected. With a well shielded sensitive gamma counter and prolonged counting times, the error from low counting rates is minimal and insignificant compared with that from incomplete urine collection. Another important consideration is the adequacy of binding of the cyanocobalamin to the chicken serum. Unbound vitamin B12 must not be present, or this will greatly increase apparent absorption. It is advised that the binding capacity of each batch of chicken serum should be measured, although we found little variability.
The protein bound part of the test gave higher absorption than our original protein bound test,4 probably because of the reduced proportion of chicken serum to vitamin B12. The decreased absorption in the elderly, however, in alcohol abusers, and in most patients with iron deficiency who had subnormal vitamin B12 concentrations was again evident. This probably indicates hypochlorhydria.
In nine patients the aqueous absorption was reduced, but protein bound absorption was normal. The results in three of these patients, two with pernicious .anaemia and one after partial gastrectomy, must be anomalous, probably due to the presence of free vitamin B12 in the protein bound dose due to an error in measuring the volume of chicken serum or isotope. Similar discrepancies occurred in two patients with iron deficiency and one with folate 636 Gozzard, Dawson, Lewis group.bmj.com on August 15, 2017 -Published by http://jcp.bmj.com/ Downloaded from deficiency, and may be due to the same cause; this emphasises the need for particular care in preparing the protein bound dose. The three other patients with the anomalous result had malabsorptive states, a high proportion of the group. This has previously been seen in two patients with gluten enteropathy investigated by our original protein bound test,4 and requires further study.
Further developments to eliminate anomalous results are necessary. The test would also be more effective if protein bound excretion in normal subjects could be enhanced. Although we have evaluated the test in a variety of conditions associated with low serum vitamin B12 concentrations, we believe its real usefulness lies in the investigation of patients with low serum vitamin B12 concentrations for which the cause is unknown. A dual test is appropriate in these circumstances because the Schilling test is usually normal in these patients. In the 13 patients we evaluated, four had subnormal protein bound absorption. Many years of observation may be required before it is known how many of these will develop typical pernicious anaemia, although one developed an abnormal Schilling test one year later.
